Search

everythinglearnresearchcommunity

for

Search:↓

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Phospholipase A2 enzymes play key roles in skin health and disease.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Bovine milk-derived exosomes may improve skin, hair, gut, brain, and bone health.

Histone modification is key in treating chronic inflammatory skin diseases.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Exosomes are important for skin health and could help diagnose and treat skin diseases.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Tailored treatment plans are crucial for managing canine dermatomyositis-like disease.

Hair changes could indicate neurological diseases and help monitor treatment.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

ILC1 cells contribute to hair loss in alopecia areata.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.